Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

Kaida BioPharma is advancing targeted anti-cancer hormonal therapies to address the root cause of cancers affecting women.

These microbes produce metabolites that might be used to treat bacterial infections, cancer, type 2 diabetes, and much more.

With several surfactants to choose from, the biopharma industry is still working to identify the most effective, environmentally friendly alternatives to the surfactant Triton X-100 (TX-100). The EU ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

Method reveals unexpected behavior in molecular crowding during cell state transitions and suggests density as a biomarker for functional precision medicine.